Vetoquinol SA (EPA: VETO)

France flag France · Delayed Price · Currency is EUR
95.90
+2.90 (3.12%)
Aug 30, 2024, 5:36 PM CET
8.61%
Market Cap 1.13B
Revenue (ttm) 529.27M
Net Income (ttm) 55.56M
Shares Out 11.83M
EPS (ttm) 4.70
PE Ratio 20.42
Forward PE 19.63
Dividend 0.85 (0.89%)
Ex-Dividend Date n/a
Volume 1,276
Open 93.40
Previous Close 93.00
Day's Range 93.40 - 96.70
52-Week Range 76.30 - 110.00
Beta 0.94
Analysts n/a
Price Target n/a
Earnings Date Sep 12, 2024

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol... [Read more]

Sector Healthcare
Founded 1933
Employees 2,440
Stock Exchange Euronext Paris
Ticker Symbol VETO
Full Company Profile

News

There is no news available yet.